We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung Cancer

This study has been terminated.
(Dose over MTD reached)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01188707
First Posted: August 25, 2010
Last Update Posted: August 4, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Copenhagen University Hospital at Herlev
Bispebjerg Hospital
Onxeo
Roche Pharma AG
Information provided by:
Herlev Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: August 2012
  Estimated Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)